673 results found.
                    
Revenue Review: 3Q18 Performance Highlights and 2018 Projections for Public Companies, Continued
By Mike Evers In the exhibits below, we've added nine companies to round out our revenue review for 3Q18. As noted in last month's 
2018 Year in Review: Revenue Projections and Technology Trends
By Mike Evers In November, we published our downloadable report, 2018 Revenue Projections: Companies Over $200 Million, for the 25 largest orthopaedic companies, shown here in Exhibit 1. Sales for these 25 companies account for approximately 80% of the worldwide orthopaedic market. We p...
PeekMed Gains FDA Clearance for Pre-Op Planning Software
PeekMed® received FDA 510(k) clearance to market its 3D pre-operative planning software.
Smith & Nephew: Positive Study Results for JOURNEY II BACS Knee
New clinical evidence represents positive mid-term survivorship results on 2,059 patients with Smith & Nephew’s JOURNEY II BCS knee.
3Q18 and 9 Month 2018 Performance Highlights for Public Companies
By Mike Evers Our recap highlights 3Q18 developments and ORTHOWORLD's projection of 2018 full-year revenue for the first publicly traded orthopaedic companies to report. Exhibits 1 and 2 below show year over year company performance for 3Q18 and nine months ending September 30, 2018...
Smith & Nephew Reports 3Q18 Orthopaedic Revenue of $808.7MM, +2.0% vs. 3Q17
Smith & Nephew reports 3Q18 orthopaedic revenue of US $808.7MM, +2.0% vs. 3Q17
ConforMIS Reports 3Q18 Product Revenue of $18.3MM, +0.9% vs. 3Q17
ConforMIS posts 3Q18 product revenue of US $18.3MM, +0.9% vs 3Q17.
Zimmer Biomet Names Ivan Tornos New Group President, Orthopedics
Zimmer Biomet appointed Mr. Ivan Tornos as Group President, Orthopedics, effective November 1.
Smith & Nephew: Positive Study Result for INTERTAN Intertrochanteric Antegrade Nail
Smith & Nephew reported study results that show its INTERTAN intertrochanteric antegrade nail significantly reduced the risk of...
Joint Reconstruction Expected to Continue with Steady Growth
By Carolyn LaWell Joint reconstruction accounts for 37% of the global orthopaedic industry. We estimate that joint reconstruction product revenue surpassed $18 billion in 2017, an increase of $560.3 million or 3.2% vs. 2016. These numbers were published in
ConforMIS, Smith & Nephew Settle Patent Dispute
ConforMIS will receive US $10.5MM from Smith & Nephew to settle a 2016 patent infringement lawsuit.
Revenue Review: 1H18 Growth and 2Q18 Performance Highlights for Public Companies
by Julie A. Vetalice The 21 companies tracked below collectively grew +3.6% in 1H18 vs. 1H17, still on track to reach our estimates of +3.7% in orthopaedic industry growth for 2018 vs. 2017. Exhibits 1 and 2 reflect 1H18 results for public orthopaedic companies. The performan...
Smith & Nephew Posts 2Q18 Ortho Revenue Growth +4% YoY
ORTHOWORLD estimates Smith & Nephew 2Q18 orthopaedic revenue of US $870.8MM, +4.4% from 2Q17, and 1H18 revenue of $1,7...
Smith & Nephew Issues Notice on First-Gen JOURNEY BCS
Smith & Nephew issued an Urgent Field Safety Notice affecting certain first-generation JOURNEY BCS component...
Arthroscopy/Soft Tissue Repair Market Ripe for 6% Growth
By Carolyn LaWell Sales from arthroscopy/soft tissue repair products in 2017 surpassed $5.3 billion and grew 6.2% vs. 2016, according to our estimates published in
Public Orthopaedic Companies: 1Q18 Revenue and Growth Drivers
By Julie A. Vetalice The 21 companies tracked in Exhibits 1 and 2 collectively grew +3.1% in 1Q18 vs. 1Q17, remaining on track alongside our estimates of +3.7% in orthopaedic industry growth for 2018 vs. 2017. (Review
Trauma Market Attracts New Players
By Carolyn LaWell Trauma remains one of the more attractive markets for orthopaedic device companies due to demographics, ripeness for innovation and an increased focus on lower extremities care, to name just three factors. These strengths have led companies of all sizes—establish...
Smith & Nephew Posts 6% Growth in Knees for 1Q18
ORTHOWORLD estimates Smith & Nephew 1Q18 orthopaedic revenue of US $865.4MM, +4.7% from 1Q17.
ConforMIS Posts 1Q18 Revenue
ConforMIS announced 1Q18 revenue of US $19.7MM, -3.9% vs. 1Q17.
Anika Therapeutics Reports 1Q18 Orthobiologic Revenue
Anika Therapeutics posted 1Q18 orthobiologic revenue of US $19.5MM, -3.6% vs. 1Q17.
Integer to Divest Advanced Surgical and Orthopedics to MedPlast
Integer entered into an agreement to sell its Advanced Surgical and Orthopedics lines to MedPlast, a global servic...
Orthobiologics: Conversations with CEOs
By Carolyn LaWell At AAOS, we sat down with the CEOs of Bioventus and Histogenics to ask about the opportunities that their companies are embracing, as well as the health of the orthobiologics market. During the interviews, we noted that we identified six orthobiologic compani...
Orthopaedic Industry Reaches $49 Billion in 2017
By Carolyn LaWell Orthopaedic industry revenue reached $49.3 billion worldwide in 2017 and grew at 3.7%, ~$1.7 billion over 2016, according to our estimates to be published in
Smith & Nephew Appoints Namal Nawana as CEO
Smith & Nephew has appointed Mr. Namal Nawana as Chief Executive Officer and successor to Mr. Olivier Bohuon, effective May 2018.
Public Orthopaedic Companies: 2017 Revenue and 2018 Sales Drivers
By Julie A. Vetalice The 20 companies tracked in Exhibits 1 and 2 collectively grew +3.0% in 2017 vs. 2016. Individually, you’ll notice some stellar performance in particular segments. (Our final estimates for 2017 orthopaedic industry revenue can be found in
  • ORTHOWORLD INC.
  • 8401 Chagrin Road, Suite 18
  • Chagrin Falls, Ohio 44023 USA
  • Phone: 440.543.2101 • Fax: 440.543.2122
  • ©1992-2018 ORTHOWORLD
  • All Rights Reserved.
  • Site Managed By:
  • Open Professional Group